USPTO serial 78241360
DYNAVAX
Reviewed by CopyMark Law Group
Status 622
- Filing date
- —
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- UNKNOWN
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DYNAVAX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Beth M. Goldman
BETH M GOLDMAN HELLER EHRMAN WHITE & MCAULIFFE LLP333 BUSH STSAN FRANCISCO, CA 94104-2878UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Pharmaceutical and biological research, testing and product development consultation; pharmaceutical and biological research, testing and product development for others; vaccine research and development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| No prosecution events are listed. | |||